Option Care Health, Inc.
OPCH
Peringkat dalam Saham
#3630
Option Care Health, Inc. delivers infusion services to patients in their homes... Option Care Health, Inc. delivers infusion services to patients in their homes and other non-hospital settings throughout the United States. The company offers a broad spectrum of specialized infusion treatments, including therapies for various infections, management of heart failure, and comprehensive nutritional support (both intravenous and tube feeding) for individuals with acute or chronic conditions such as stroke, cancer, and digestive illnesses. They also provide immunoglobulin infusions for immune system deficiencies and treatments targeting chronic inflammatory disorders like Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis. Furthermore, Option Care Health assists in managing the progression of neurological conditions such as amyotrophic lateral sclerosis (ALS) and Duchenne muscular dystrophy. They also administer infusion therapies for bleeding disorders and provide crucial support for women experiencing high-risk pregnancies. Other specialized infusion services encompass pain relief, chemotherapy, and respiratory care. Complementing these medical offerings, the company provides professional nursing services. Option Care Health, Inc. maintains its primary corporate office in Bannockburn, Illinois.
Harga Saham
$31.26
Kapitalisasi Pasar
$4.68B
Perubahan (1 hari)
0.16%
Perubahan (1 tahun)
10.15%
Negara
US
Perdagangan Option Care Health, Inc. (OPCH)
Kategori
Healthcare
Rasio P/B untuk Option Care Health, Inc. (OPCH)
Rasio P/B per October 2026 TTM: 3.82
Menurut laporan keuangan dan harga saham terbaru dari Option Care Health, Inc., rasio P/B saat ini (TTM) adalah 3.82. Pada akhir 2023, rasio P/B perusahaan adalah 4.24.
Riwayat rasio P/B untuk Option Care Health, Inc. dari 2000 hingga 2026
Rasio P/B pada akhir setiap tahun
| Tahun | Rasio P/B | Mengubah |
|---|---|---|
| 2026 (TTM) | 3.82 | 35.10% |
| 2024 | 2.83 | -33.17% |
| 2023 | 4.24 | 7.88% |
| 2022 | 3.93 | -9.62% |
| 2021 | 4.35 | 56.10% |
| 2020 | 2.79 | 8.37% |
| 2019 | 2.57 | -181.07% |
| 2018 | -3.17 | -28.59% |
| 2017 | -4.44 | 43.80% |
| 2016 | -3.09 | 107.76% |
| 2015 | -1.49 | -167.34% |
| 2014 | 2.21 | 63.86% |
| 2013 | 1.35 | -34.73% |
| 2012 | 2.06 | 49.33% |
| 2011 | 1.38 | 5.00% |
| 2010 | 1.32 | -37.07% |
| 2009 | 2.09 | 134.35% |
| 2008 | 0.89 | -49.01% |
| 2007 | 1.75 | 119.52% |
| 2006 | 0.80 | -39.32% |
| 2005 | 1.31 | 7.48% |
| 2004 | 1.22 | -15.86% |
| 2003 | 1.45 | 4.39% |
| 2002 | 1.39 | -77.75% |
| 2001 | 6.26 | 1,294.92% |
| 2000 | 0.45 | 0.00% |
Rasio P/B untuk perusahaan sejenis atau pesaing
| Perusahaan | Rasio P/B | Perbedaan Rasio P/B | Negara |
|---|---|---|---|
| -15.9433 | -517.01% |
US
|
|
| - | - |
DE
|
|
| 4.8701 | 27.38% |
US
|
|
| 9.3882 | 145.56% |
SA
|
|
| 4.6058 | 20.47% |
BR
|
